ENGLEWOOD, Colo., Mar.3, 2021 / PRNewswire / – Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on advancing immunologic therapies for common inflammatory conditions, today released its annual financial results for the year closed December 31, 2020 and provided a company overview / company update.
Mr. Michael Macaluso, President and CEO, said: “The FDA recently responded to our requests to expand our IV and Inhalation Covid-19 studies, using Ampion, recommending that we conduct a randomized Phase II, double blind and placebo controlled. test in each. They also indicated that their recommended test design for both will allow for an effective and efficient review. data results, determine safety and statistical significance …
News Highlights Business
- Headline: Ampio Pharmaceuticals, Inc. Reports Fourth Quarter 2020 Financial Results and Business Update
- Check all news and articles from the Business news updates.